Journal of General Virology, Vol 80, 601-606, Copyright © 1999 by Society for General Microbiology

ARTICLES

Functional analysis of mutations conferring lamivudine resistance on hepatitis B virus

R Ling and TJ Harrison
Department of Medicine, Royal Free and University College Medical School, University College London, UK.

Two patterns of mutation are commonly observed in the polymerase gene of lamivudine [(-)2'-deoxy-3'-thiacytidine]-resistant hepatitis B virus (HBV). The M539I substitution in the conserved YMDD motif occurs independently of other changes, whereas the M539V substitution is associated with an additional upstream change (L515M). These mutations were introduced into a common background and their effects on HBV DNA replication and lamivudine resistance studied. The L515M and M539V mutations provided only partial resistance while the M539I mutation conferred a high degree of lamivudine resistance. The combination of the L515M and M539V mutations gave an intermediate level of replication competence, compared with either mutation alone, and increased resistance to lamivudine. This probably accounts for these two mutations always being observed together. The M539I mutation reduced replication competence.

This article has been cited by other articles:

				N. Warner, S. Locarnini, M. Kuiper, A. Bartholomeusz, A. Ayres, L. Yuen, and T. Shaw The L80I Substitution in the Reverse Transcriptase Domain of the Hepatitis B Virus Polymerase Is Associated with Lamivudine Resistance and Enhanced Viral Replication In Vitro Antimicrob. Agents Chemother., July 1, 2007; 51(7): 2285 - 2292. [Abstract] [Full Text] [PDF]

				M.-F. Yuen, H.-J. Yuan, E. Sablon, D. K.-H. Wong, A. O.-O. Chan, B. C.-Y. Wong, and C.-L. Lai Long-Term Follow-Up Study of Chinese Patients with YMDD Mutations: Significance of Hepatitis B Virus Genotypes and Characteristics of Biochemical Flares J. Clin. Microbiol., September 1, 2004; 42(9): 3932 - 3936. [Abstract] [Full Text] [PDF]

				K.-A. Walters, G. A. Tipples, M. I. Allen, L. D. Condreay, W. R. Addison, and L. Tyrrell Generation of Stable Cell Lines Expressing Lamivudine-Resistant Hepatitis B Virus for Antiviral-Compound Screening Antimicrob. Agents Chemother., June 1, 2003; 47(6): 1936 - 1942. [Abstract] [Full Text] [PDF]

				R. K. Gaillard, J. Barnard, V. Lopez, P. Hodges, E. Bourne, L. Johnson, M. I. Allen, P. Condreay, W. H. Miller, and L. D. Condreay Kinetic Analysis of Wild-Type and YMDD Mutant Hepatitis B Virus Polymerases and Effects of Deoxyribonucleotide Concentrations on Polymerase Activity Antimicrob. Agents Chemother., April 1, 2002; 46(4): 1005 - 1013. [Abstract] [Full Text] [PDF]

				K. Das, X. Xiong, H. Yang, C. E. Westland, C. S. Gibbs, S. G. Sarafianos, and E. Arnold Molecular Modeling and Biochemical Characterization Reveal the Mechanism of Hepatitis B Virus Polymerase Resistance to Lamivudine (3TC) and Emtricitabine (FTC) J. Virol., May 15, 2001; 75(10): 4771 - 4779. [Abstract] [Full Text]

				L. Fu and Y.-C. Cheng Characterization of Novel Human Hepatoma Cell Lines with Stable Hepatitis B Virus Secretion for Evaluating New Compounds against Lamivudine- and Penciclovir-Resistant Virus Antimicrob. Agents Chemother., December 1, 2000; 44(12): 3402 - 3407. [Abstract] [Full Text]